/case-studies / pharma-ai-act-readiness
AI GOVERNANCE, RISK & TRUST

EU AI Act readiness for a global pharmaceutical company

client
Global Pharma
industry
Pharmaceuticals
services
AI Governance · Consulting
duration
6 months
fig.80// skillikzmodeltraininfervectorAImodel.evalrollout73%98%accuracyusage81coveragelive
// OVERVIEW

Global Pharma — a pharmaceuticals organisation — engaged Skillikz on ai act readiness: Inventory, risk-rating and controls for enterprise AI. This case study sets out the business challenge, the AI-led approach we took, the technologies involved and the measurable outcomes delivered over 6 months.

// TECHNOLOGIES
Model RegistryEvaluation SuiteGuardrailsPythonAudit Logging
100%
AI inventoried
AI Act
aligned
0
unmanaged models
audit
ready
01 // THE CHALLENGE

AI was spreading across R&D and operations with no central view of where it ran, how risky it was, or whether it met incoming regulation.

02 // OUR APPROACH

We inventoried and risk-rated every AI system, then put proportionate guardrails, testing and monitoring in place against the EU AI Act and ISO 42001.

Enterprise-wide AI inventory and classification
EU AI Act / ISO 42001 gap assessment
Guardrails, policy and monitoring controls
Governance operating model and roadmap
03 // THE RESULTS

The company has a complete, risk-rated AI inventory, proportionate controls, and an audit-ready posture aligned to the EU AI Act.

We went from 'we think we're fine' to evidence we can show a regulator.

Chief Risk Officer · Global Pharma
// HOW WE'D DELIVER THIS TODAY

The AI services behind this outcome

A project like this draws on a focused set of Skillikz services — from first assessment to a working pilot and a clear path to scale.

// MORE WORK
→ all_case_studies

Want outcomes like these?

Tell us your challenge and we'll map an AI-led path to measurable results.

[ start_a_conversation → ]